Acute bacterial skin and skin-structure infections (ABSSSIs) collect a cluster of common types of infection, including abscesses, cellulitis, and wound infections, that require an immediate effective antibacterial treatment. The high level of resistance to many antibiotic drugs in the prevalent pathogens, mainly methicillin-resistant Staphylococcus aureus (MRSA), and the presence of risk factors and comorbidities make the appropriate selection of the antibiotic highly challenging. In recent years, new antibiotics have been developed with a spectrum targeted at Gram-positive bacteria and MRSA. Among them, dalbavancin, an effective long-acting antibiotic, can reduce the hospitalization time of patients, decreasing the risk of hospital infections and saving the costs of therapy. The current paper highlights the key management time-points that treating physicians must be aware of in order to achieve clinical success and to discharge patients from the hospital as early as possible.

Protocollo diagnostico-terapeutico del paziente con infezioni acute di cute e strutture cutanee (ABSSSI) nel setting ospedaliero e ambulatoriale: take home messages

CULTRERA, ROSARIO
Primo
Writing – Original Draft Preparation
;
MAGNANI, GIULIA
Secondo
Investigation
;
QUARTA, BRUNELLA
Resources
;
MARRA, ANNA
Resources
;
TURRINI, FRANCESCO
Membro del Collaboration Group
;
LIBANORE, MARCO
Penultimo
Writing – Review & Editing
;
2019

Abstract

Acute bacterial skin and skin-structure infections (ABSSSIs) collect a cluster of common types of infection, including abscesses, cellulitis, and wound infections, that require an immediate effective antibacterial treatment. The high level of resistance to many antibiotic drugs in the prevalent pathogens, mainly methicillin-resistant Staphylococcus aureus (MRSA), and the presence of risk factors and comorbidities make the appropriate selection of the antibiotic highly challenging. In recent years, new antibiotics have been developed with a spectrum targeted at Gram-positive bacteria and MRSA. Among them, dalbavancin, an effective long-acting antibiotic, can reduce the hospitalization time of patients, decreasing the risk of hospital infections and saving the costs of therapy. The current paper highlights the key management time-points that treating physicians must be aware of in order to achieve clinical success and to discharge patients from the hospital as early as possible.
2019
Cultrera, Rosario; Magnani, Giulia; Quarta, Brunella; Marra, Anna; Turrini, Francesco; Libanore, Marco; Taglietti, Camilla
File in questo prodotto:
File Dimensione Formato  
Monografia_Xydalba_Rev.pdf

accesso aperto

Tipologia: Full text (versione editoriale)
Licenza: PUBBLICO - Pubblico con Copyright
Dimensione 5.26 MB
Formato Adobe PDF
5.26 MB Adobe PDF Visualizza/Apri

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2419108
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact